Logo image of BG

BUNGE GLOBAL SA (BG) Stock Fundamental Analysis

USA - NYSE:BG - CH1300646267 - Common Stock

84.13 USD
+0.16 (+0.19%)
Last: 10/6/2025, 9:24:26 PM
83.93 USD
-0.2 (-0.24%)
After Hours: 10/6/2025, 9:24:26 PM
Fundamental Rating

5

Overall BG gets a fundamental rating of 5 out of 10. We evaluated BG against 87 industry peers in the Food Products industry. Both the profitability and the financial health of BG get a neutral evaluation. Nothing too spectacular is happening here. BG is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BG had positive earnings in the past year.
BG had a positive operating cash flow in the past year.
In the past 5 years BG has always been profitable.
In multiple years BG reported negative operating cash flow during the last 5 years.
BG Yearly Net Income VS EBIT VS OCF VS FCFBG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B -6B

1.2 Ratios

The Return On Assets of BG (4.42%) is better than 67.82% of its industry peers.
BG has a better Return On Equity (12.66%) than 75.86% of its industry peers.
BG's Return On Invested Capital of 5.23% is in line compared to the rest of the industry. BG outperforms 57.47% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BG is significantly below the industry average of 28.37%.
The 3 year average ROIC (10.77%) for BG is well above the current ROIC(5.23%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 4.42%
ROE 12.66%
ROIC 5.23%
ROA(3y)6.65%
ROA(5y)6.66%
ROE(3y)16.17%
ROE(5y)18.73%
ROIC(3y)10.77%
ROIC(5y)10.22%
BG Yearly ROA, ROE, ROICBG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

With a Profit Margin value of 2.71%, BG perfoms like the industry average, outperforming 58.62% of the companies in the same industry.
In the last couple of years the Profit Margin of BG has declined.
Looking at the Operating Margin, with a value of 3.24%, BG is in line with its industry, outperforming 49.43% of the companies in the same industry.
In the last couple of years the Operating Margin of BG has grown nicely.
BG's Gross Margin of 6.27% is on the low side compared to the rest of the industry. BG is outperformed by 80.46% of its industry peers.
BG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.24%
PM (TTM) 2.71%
GM 6.27%
OM growth 3Y-7.82%
OM growth 5Y6.69%
PM growth 3Y-14.75%
PM growth 5YN/A
GM growth 3Y2.27%
GM growth 5Y3.43%
BG Yearly Profit, Operating, Gross MarginsBG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BG is still creating some value.
The number of shares outstanding for BG has been reduced compared to 1 year ago.
Compared to 5 years ago, BG has less shares outstanding
Compared to 1 year ago, BG has a worse debt to assets ratio.
BG Yearly Shares OutstandingBG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
BG Yearly Total Debt VS Total AssetsBG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

An Altman-Z score of 3.32 indicates that BG is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.32, BG is doing good in the industry, outperforming 68.97% of the companies in the same industry.
BG has a Debt/Equity ratio of 0.97. This is a neutral value indicating BG is somewhat dependend on debt financing.
BG's Debt to Equity ratio of 0.97 is on the low side compared to the rest of the industry. BG is outperformed by 68.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Altman-Z 3.32
ROIC/WACC0.69
WACC7.55%
BG Yearly LT Debt VS Equity VS FCFBG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B

2.3 Liquidity

BG has a Current Ratio of 2.07. This indicates that BG is financially healthy and has no problem in meeting its short term obligations.
BG has a Current ratio of 2.07. This is in the better half of the industry: BG outperforms 65.52% of its industry peers.
A Quick Ratio of 1.29 indicates that BG should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.29, BG is doing good in the industry, outperforming 72.41% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 1.29
BG Yearly Current Assets VS Current LiabilitesBG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

BG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.21%.
Measured over the past years, BG shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.28% on average per year.
The Revenue has decreased by -8.88% in the past year.
Measured over the past years, BG shows a small growth in Revenue. The Revenue has been growing by 5.24% on average per year.
EPS 1Y (TTM)-34.21%
EPS 3Y-10.8%
EPS 5Y20.28%
EPS Q2Q%-24.28%
Revenue 1Y (TTM)-8.88%
Revenue growth 3Y-3.53%
Revenue growth 5Y5.24%
Sales Q2Q%-3.56%

3.2 Future

Based on estimates for the next years, BG will show a small growth in Earnings Per Share. The EPS will grow by 0.67% on average per year.
The Revenue is expected to grow by 8.76% on average over the next years. This is quite good.
EPS Next Y-16.85%
EPS Next 2Y-3.4%
EPS Next 3Y0.67%
EPS Next 5YN/A
Revenue Next Year-1.55%
Revenue Next 2Y1.93%
Revenue Next 3Y8.76%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BG Yearly Revenue VS EstimatesBG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B
BG Yearly EPS VS EstimatesBG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.16, the valuation of BG can be described as reasonable.
Based on the Price/Earnings ratio, BG is valued cheaper than 81.61% of the companies in the same industry.
When comparing the Price/Earnings ratio of BG to the average of the S&P500 Index (27.90), we can say BG is valued rather cheaply.
BG is valuated reasonably with a Price/Forward Earnings ratio of 9.81.
Based on the Price/Forward Earnings ratio, BG is valued cheaply inside the industry as 91.95% of the companies are valued more expensively.
BG is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.36, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.16
Fwd PE 9.81
BG Price Earnings VS Forward Price EarningsBG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BG is valued a bit cheaper than the industry average as 74.71% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.41
BG Per share dataBG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.55
EPS Next 2Y-3.4%
EPS Next 3Y0.67%

6

5. Dividend

5.1 Amount

BG has a Yearly Dividend Yield of 3.37%. Purely for dividend investing, there may be better candidates out there.
BG's Dividend Yield is a higher than the industry average which is at 4.91.
Compared to an average S&P500 Dividend Yield of 2.44, BG pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.37%

5.2 History

The dividend of BG has a limited annual growth rate of 3.89%.
BG has paid a dividend for at least 10 years, which is a reliable track record.
BG has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.89%
Div Incr Years4
Div Non Decr Years23
BG Yearly Dividends per shareBG Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

BG pays out 27.00% of its income as dividend. This is a sustainable payout ratio.
BG's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP27%
EPS Next 2Y-3.4%
EPS Next 3Y0.67%
BG Yearly Income VS Free CF VS DividendBG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B -6B
BG Dividend Payout.BG Dividend Payout, showing the Payout Ratio.BG Dividend Payout.PayoutRetained Earnings

BUNGE GLOBAL SA

NYSE:BG (10/6/2025, 9:24:26 PM)

After market: 83.93 -0.2 (-0.24%)

84.13

+0.16 (+0.19%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-28 2025-10-28/bmo
Inst Owners74.64%
Inst Owner Change0%
Ins Owners0.81%
Ins Owner Change4.97%
Market Cap16.83B
Analysts79
Price Target92.75 (10.25%)
Short Float %3.43%
Short Ratio2.8
Dividend
Industry RankSector Rank
Dividend Yield 3.37%
Yearly Dividend2.71
Dividend Growth(5Y)3.89%
DP27%
Div Incr Years4
Div Non Decr Years23
Ex-Date11-17 2025-11-17 (0.7)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.59%
Min EPS beat(2)11.48%
Max EPS beat(2)35.7%
EPS beat(4)3
Avg EPS beat(4)10.71%
Min EPS beat(4)-7.78%
Max EPS beat(4)35.7%
EPS beat(8)6
Avg EPS beat(8)12.16%
EPS beat(12)8
Avg EPS beat(12)13.44%
EPS beat(16)11
Avg EPS beat(16)22.64%
Revenue beat(2)1
Avg Revenue beat(2)-5.3%
Min Revenue beat(2)-13.41%
Max Revenue beat(2)2.81%
Revenue beat(4)1
Avg Revenue beat(4)-3.96%
Min Revenue beat(4)-13.41%
Max Revenue beat(4)2.81%
Revenue beat(8)1
Avg Revenue beat(8)-5.75%
Revenue beat(12)3
Avg Revenue beat(12)-5.52%
Revenue beat(16)5
Avg Revenue beat(16)-3.86%
PT rev (1m)0%
PT rev (3m)1.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-37.64%
EPS NY rev (1m)0.57%
EPS NY rev (3m)-4.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.98%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)1.45%
Valuation
Industry RankSector Rank
PE 11.16
Fwd PE 9.81
P/S 0.33
P/FCF N/A
P/OCF 16.45
P/B 1.55
P/tB 1.67
EV/EBITDA 7.41
EPS(TTM)7.54
EY8.96%
EPS(NY)8.58
Fwd EY10.19%
FCF(TTM)-2.68
FCFYN/A
OCF(TTM)5.11
OCFY6.08%
SpS254.23
BVpS54.4
TBVpS50.52
PEG (NY)N/A
PEG (5Y)0.55
Profitability
Industry RankSector Rank
ROA 4.42%
ROE 12.66%
ROCE 7.94%
ROIC 5.23%
ROICexc 7.68%
ROICexgc 8.06%
OM 3.24%
PM (TTM) 2.71%
GM 6.27%
FCFM N/A
ROA(3y)6.65%
ROA(5y)6.66%
ROE(3y)16.17%
ROE(5y)18.73%
ROIC(3y)10.77%
ROIC(5y)10.22%
ROICexc(3y)12.86%
ROICexc(5y)11.97%
ROICexgc(3y)13.65%
ROICexgc(5y)12.78%
ROCE(3y)14.6%
ROCE(5y)14.18%
ROICexcg growth 3Y-15.42%
ROICexcg growth 5Y5.22%
ROICexc growth 3Y-14.88%
ROICexc growth 5Y6.42%
OM growth 3Y-7.82%
OM growth 5Y6.69%
PM growth 3Y-14.75%
PM growth 5YN/A
GM growth 3Y2.27%
GM growth 5Y3.43%
F-Score4
Asset Turnover1.63
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Debt/EBITDA 4.97
Cap/Depr 326.15%
Cap/Sales 3.07%
Interest Coverage 250
Cash Conversion 48.07%
Profit Quality N/A
Current Ratio 2.07
Quick Ratio 1.29
Altman-Z 3.32
F-Score4
WACC7.55%
ROIC/WACC0.69
Cap/Depr(3y)226.28%
Cap/Depr(5y)171.37%
Cap/Sales(3y)1.77%
Cap/Sales(5y)1.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.21%
EPS 3Y-10.8%
EPS 5Y20.28%
EPS Q2Q%-24.28%
EPS Next Y-16.85%
EPS Next 2Y-3.4%
EPS Next 3Y0.67%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.88%
Revenue growth 3Y-3.53%
Revenue growth 5Y5.24%
Sales Q2Q%-3.56%
Revenue Next Year-1.55%
Revenue Next 2Y1.93%
Revenue Next 3Y8.76%
Revenue Next 5YN/A
EBIT growth 1Y-26.83%
EBIT growth 3Y-11.07%
EBIT growth 5Y12.28%
EBIT Next Year14.94%
EBIT Next 3Y15.24%
EBIT Next 5YN/A
FCF growth 1Y64.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y265%
OCF growth 3YN/A
OCF growth 5YN/A